Mol. Cells 2012; 33(2): 127-133
Published online January 2, 2012
https://doi.org/10.1007/s10059-012-2182-8
© The Korean Society for Molecular and Cellular Biology
Correspondence to : *Correspondence: sunjungk@dongguk.edu (SJK); ranliu@seu.edu.cn (RL)
Epigenetic methylation change is a major process that occurs during cancer development. Even though many tumor-related genes have been identified based on their relationship between methylation and expression, few stu-dies have been conducted to investigate the relevant biological pathways involved in these changes. To identify essential pathways likely to be affected by methylation in breast cancer, we examined a pool of genes in which expression was upregulated after induction of demethy-lation by 5-Aza-2?-deoxycytidine (Aza) in the MCF-7 breast cancer cell line. Genome-wide demethylation was confir-med by monitoring the demethylation of a previously known gene, SULT1A1. Overall, 210 and 213 genes were found to be upregulated and downregulated (fold change > 2), respectively, in common in cells treated with 5 and 10 ?M of Aza. Network analysis of these 423 genes with altered expres-sion patterns identified the involvement of a cancer related network of genes that were heavily regulated by TNF-? in breast tumorigenesis. Our results suggest that epigenetic dysregulation of cellular processes relevant to TNF-?-dependent apoptosis may be intimately involved in tumorigenesis in MCF-7 cells.
Keywords 5-Aza-2'deoxycytidine, breast cancer, genome-wide expression, MCF-7, TNF-alpha
Mol. Cells 2012; 33(2): 127-133
Published online February 29, 2012 https://doi.org/10.1007/s10059-012-2182-8
Copyright © The Korean Society for Molecular and Cellular Biology.
Ju Hee Kim1,3, Seongeun Kang1,3, Tae Woo Kim1, Lihong Yin2, Ran Liu2,*, and Sun Jung Kim1,*
1Department of Life Science, Dongguk University-Seoul, Seoul 100-715, Korea, 2Key Laboratory of Environmental Medicine Engineering, Ministry of Education, School of Public Health, Southeast University, Nanjing 210009, China, 3These authors contributed equally to this work.
Correspondence to:*Correspondence: sunjungk@dongguk.edu (SJK); ranliu@seu.edu.cn (RL)
Epigenetic methylation change is a major process that occurs during cancer development. Even though many tumor-related genes have been identified based on their relationship between methylation and expression, few stu-dies have been conducted to investigate the relevant biological pathways involved in these changes. To identify essential pathways likely to be affected by methylation in breast cancer, we examined a pool of genes in which expression was upregulated after induction of demethy-lation by 5-Aza-2?-deoxycytidine (Aza) in the MCF-7 breast cancer cell line. Genome-wide demethylation was confir-med by monitoring the demethylation of a previously known gene, SULT1A1. Overall, 210 and 213 genes were found to be upregulated and downregulated (fold change > 2), respectively, in common in cells treated with 5 and 10 ?M of Aza. Network analysis of these 423 genes with altered expres-sion patterns identified the involvement of a cancer related network of genes that were heavily regulated by TNF-? in breast tumorigenesis. Our results suggest that epigenetic dysregulation of cellular processes relevant to TNF-?-dependent apoptosis may be intimately involved in tumorigenesis in MCF-7 cells.
Keywords: 5-Aza-2'deoxycytidine, breast cancer, genome-wide expression, MCF-7, TNF-alpha
Min Ji Park, Eunji Jeong, Eun Ji Lee, Hyeon Ji Choi, Bo Hyun Moon, Keunsoo Kang, and Suhwan Chang
Mol. Cells 2023; 46(6): 351-359 https://doi.org/10.14348/molcells.2023.2174Hee Min Yoo, Jong Ho Park, Jae Yeon Kim, and Chin Ha Chung
Mol. Cells 2022; 45(6): 425-434 https://doi.org/10.14348/molcells.2022.0029Jin-Ah Park, Han-Heom Na, Hyeon-Ok Jin, and Keun-Cheol Kim
Mol. Cells 2019; 42(12): 884-892 https://doi.org/10.14348/molcells.2019.0088